Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

Journal of Lipid Research

Volumn 56, Issue 11, 2015, Pages 2048-2060

  Tang, Xiaoyun ^a   Benesch, Matthew G K ^a   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autotaxin; Breast cancer; Cell migration; Epidermal growth factor (EGF) receptor; G protein coupled receptors; Lysophosphatidate; Thyroid cancer

Indexed keywords

CERAMIDE 1 PHOSPHATE; LIPID PHOSPHATE PHOSPHATASE; PHOSPHOTRANSFERASE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; LYSOPHOSPHOLIPID; PHOSPHATIDATE PHOSPHATASE;

CATALYSIS; CELL GROWTH; CELL MEMBRANE; CRYSTALLOGRAPHY; CYTOTOXICITY; DIMERIZATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STRUCTURE; GENOTYPE; GLYCOSYLATION; HETEROZYGOSITY; HUMAN; HYDROLYSIS; HYDROPHOBICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; LIPID METABOLISM; METABOLISM; NEOPLASM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; ERBB RECEPTORS; HUMANS; LIPID METABOLISM; LYSOPHOSPHOLIPIDS; NEOPLASMS; PHOSPHATIDATE PHOSPHATASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84937237383     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R058362     Document Type: Review

References (159)

1. Jamal, Z., A. Martin, A. Gomez-Munoz, and D. N. Brindley. 1991. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J. Biol. Chem. 266 : 2988 - 2996.
2. Kok, B. P., G. Venkatraman, D. Capatos, and D. N. Brindley. 2012. Unlike two peas in a pod: lipid phosphate phosphatases and phosphatidate phosphatases. Chem. Rev. 112 : 5121 - 5146.
3. Han, G. S., W. I. Wu, and G. M. Carman. 2006. The Saccharomyces cerevisiae lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J. Biol. Chem. 281 : 9210 - 9218.
4. Donkor, J., M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue. 2007. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282 : 3450 - 3457.
5. Waggoner, D. W., A. Gomez-Munoz, J. Dewald, and D. N. Brindley. 1996. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate. J. Biol. Chem. 271 : 16506 - 16509.
6. Dillon, D. A., X. Chen, G. M. Zeimetz, W. I. Wu, D. W. Waggoner, J. Dewald, D. N. Brindley, and G. M. Carman. 1997. Mammalian Mg2+-independent phosphatidate phosphatase (PAP2) displays diacylglycerol pyrophosphate phosphatase activity. J. Biol. Chem. 272 : 10361 - 10366.
7. Hooks, S. B., S. P. Ragan, and K. R. Lynch. 1998. Identifi cation of a novel human phosphatidic acid phosphatase type 2 isoform. FEBS Lett. 427 : 188 - 192.
8. Brindley, D. N., and D. W. Waggoner. 1998. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273 : 24281 - 24284.
9. Kai, M., I. Wada, S. Imai, F. Sakane, and H. Kanoh. 1996. Identifi cation and cDNA cloning of 35-kDa phosphatidic acid phosphatase (type 2) bound to plasma membranes. Polymerase chain reaction amplifi cation of mouse H2O2-inducible hic53 clone yielded the cDNA encoding phosphatidic acid phosphatase. J. Biol. Chem. 271 : 18931 - 18938.
10. Kai, M., I. Wada, S. Imai, F. Sakane, and H. Kanoh. 1997. Cloning and characterization of two human isozymes of Mg2+- independent phosphatidic acid phosphatase. J. Biol. Chem. 272 : 24572 - 24578.
11. Toke, D. A., W. L. Bennett, J. Oshiro, W. I. Wu, D. R. Voelker, and G. M. Carman. 1998. Isolation and characterization of the Saccharomyces cerevisiae LPP1 gene encoding a Mg2+-independent phosphatidate phosphatase. J. Biol. Chem. 273 : 14331 - 14338.
12. Toke, D. A., W. L. Bennett, D. A. Dillon, W. I. Wu, X. Chen, D. B. Ostrander, J. Oshiro, A. Cremesti, D. R. Voelker, A. S. Fischl, et al. 1998. Isolation and characterization of the Saccharomyces cerevisiae DPP1 gene encoding diacylglycerol pyrophosphate phosphatase. J. Biol. Chem. 273 : 3278 - 3284.
13. Hemrika, W., R. Renirie, H. L. Dekker, P. Bernett, and R. Wever. 1997. From phosphatases to vanadium peroxidases: A similar architecture of the active site. Proc. Natl. Acad. Sci. USA. 94 : 2145 - 2149.
14. Neuwald, A. F. 1997. An unexpected structural relationship between integral membrane phosphatases and soluble haloperoxidases. Protein Sci. 6 : 1764 - 1767.
15. Brindley, D. N., D. English, C. Pilquil, K. Buri, and Z. C. Ling. 2002. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids. Biochim. Biophys. Acta. 1582 : 33 - 44.
16. Carman, G. M., and G. S. Han. 2009. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J. Biol. Chem. 284 : 2593 - 2597.
17. Stukey, J., and G. M. Carman. 1997. Identifi cation of a novel phosphatase sequence motif. Protein Sci. 6 : 469 - 472.
18. Icho, T., and C. R. Raetz. 1983. Multiple genes for membranebound phosphatases in Escherichia coli and their action on phospholipid precursors. J. Bacteriol. 153 : 722 - 730.
19. Dillon, D. A., W. I. Wu, B. Riedel, J. B. Wissing, W. Dowhan, and G. M. Carman. 1996. The Escherichia coli pgpB gene encodes for a diacylglycerol pyrophosphate phosphatase activity. J. Biol. Chem. 271 : 30548 - 30553.
20. Simons, B. H., P. Barnett, E. G. Vollenbroek, H. L. Dekker, A. O. Muijsers, A. Messerschmidt, and R. Wever. 1995. Primary structure and characterization of the vanadium chloroperoxidase from the fungus Curvularia inaequalis. Eur. J. Biochem. 229 : 566 - 574.
21. Mao, C., M. Wadleigh, G. M. Jenkins, Y. A. Hannun, and L. M. Obeid. 1997. Identifi cation and characterization of Saccharomyces cerevisiae dihydrosphingosine-1-phosphate phosphatase. J. Biol. Chem. 272 : 28690 - 28694.
22. Mandala, S. M., R. Thornton, Z. Tu, M. B. Kurtz, J. Nickels, J. Broach, R. Menzeleev, and S. Spiegel. 1998. Sphingoid base 1-phosphate phosphatase: A key regulator of sphingolipid metabolism and stress response. Proc. Natl. Acad. Sci. USA. 95 : 150 - 155.
23. Mandala, S. M. 2001. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 64 : 143 - 156.
24. Shelly, L. L., K. J. Lei, C. J. Pan, S. F. Sakata, S. Ruppert, G. Schutz, and J. Y. Chou. 1993. Isolation of the gene for murine glucose- 6-phosphatase, the enzyme defi cient in glycogen storage disease type 1A. J. Biol. Chem. 268 : 21482 - 21485.
25. Fukunaga, K., M. Arita, M. Takahashi, A. J. Morris, M. Pfeffer, and B. D. Levy. 2006. Identifi cation and functional characterization of a presqualene diphosphate phosphatase. J. Biol. Chem. 281 : 9490 - 9497.
26. Toke, D. A., M. L. McClintick, and G. M. Carman. 1999. Mutagenesis of the phosphatase sequence motif in diacylglycerol pyrophosphate phosphatase from Saccharomyces cerevisiae. Biochemistry. 38 : 14606 - 14613.
27. Zhang, Q. X., C. S. Pilquil, J. Dewald, L. G. Berthiaume, and D. N. Brindley. 2000. Identifi cation of structurally important domains of lipid phosphate phosphatase-1: implications for its sites of action. Biochem. J. 345 : 181 - 184.
28. Kok, B. P., P. C. Kienesberger, J. R. Dyck, and D. N. Brindley. 2012. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 defi cient (fl d) mice. J. Lipid Res. 53 : 105 - 118.
29. Brindley, D. N., and C. Pilquil. 2009. Lipid phosphate phosphatases and signaling. J. Lipid Res. 50 ( Suppl ): S225 - S230.
30. Brindley, D. N. 2004. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J. Cell. Biochem. 92 : 900 - 912.
31. Sigal, Y. J., M. I. McDermott, and A. J. Morris. 2005. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 387 : 281 - 293.
32. Messerschmidt, A., and R. Wever. 1996. X-ray structure of a vanadium- containing enzyme: chloroperoxidase from the fungus Curvularia inaequalis. Proc. Natl. Acad. Sci. USA. 93 : 392 - 396.
33. Messerschmidt, A., L. Prade, and R. Wever. 1997. Implications for the catalytic mechanism of the vanadium-containing enzyme chloroperoxidase from the fungus Curvularia inaequalis by X-ray structures of the native and peroxide form. Biol. Chem. 378 : 309 - 315.
34. Fan, J., D. Jiang, Y. Zhao, J. Liu, and X. C. Zhang. 2014. Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B. Proc. Natl. Acad. Sci. USA. 111 : 7636 - 7640.
35. Long, J. S., N. J. Pyne, and S. Pyne. 2008. Lipid phosphate phosphatases form homo- And hetero-oligomers: catalytic competency, subcellular distribution and function. Biochem. J. 411 : 371 - 377.
36. Burnett, C., P. Makridou, L. Hewlett, and K. Howard. 2004. Lipid phosphate phosphatases dimerise, but this interaction is not required for in vivo activity. BMC Biochem. 5 : 2.
37. Moolenaar, W. H., L. A. van Meeteren, and B. N. Giepmans. 2004. The ins and outs of lysophosphatidic acid signaling. Bio Essays. 26 : 870 - 881.
38. Yue, J., K. Yokoyama, L. Balazs, D. L. Baker, D. Smalley, C. Pilquil, D. N. Brindley, and G. Tigyi. 2004. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic defi cits without alteration in circulating lysophosphatidate level. Cell. Signal. 16 : 385 - 399.
39. Fourcade, O., M. F. Simon, C. Viode, N. Rugani, F. Leballe, A. Ragab, B. Fournie, L. Sarda, and H. Chap. 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80 : 919 - 927.
40. Sano, T., D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi. 2002. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J. Biol. Chem. 277 : 21197 - 21206.
41. Brindley, D. N. 1993. Hepatic secretion of lysphosphatidylcholine: A novel transport system for polyunsaturated fatty acids and choline. J. Nutr. Biochem. 4 : 442 - 449.
42. Tokumura, A., E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa. 2002. Identifi cation of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277 : 39436 - 39442.
43. Morishige, J., K. Touchika, T. Tanaka, K. Satouchi, K. Fukuzawa, and A. Tokumura. 2007. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white. Biochim. Biophys. Acta. 1771 : 491 - 499.
44. Tigyi, G., and A. L. Parrill. 2003. Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid Res. 42 : 498 - 526.
45. Rivera, R., and J. Chun. 2008. Biological effects of lysophospholipids. Rev. Physiol. Biochem. Pharmacol. 160 : 25 - 46.
46. van Meeteren, L. A., P. Ruurs, C. Stortelers, P. Bouwman, M. A. van Rooijen, J. P. Pradere, T. R. Pettit, M. J. Wakelam, J. S. Saulnier-Blache, C. L. Mummery, et al. 2006. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 26 : 5015 - 5022.
47. Tanaka, M., S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai. 2006. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J. Biol. Chem. 281 : 25822 - 25830.
48. Bai, Z., L. Cai, E. Umemoto, A. Takeda, K. Tohya, Y. Komai, P. T. Veeraveedu, E. Hata, Y. Sugiura, A. Kubo, et al. 2013. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin/lysophosphatidic acid axis. J. Immunol. 190 : 2036 - 2048.
49. Zhang, Y., Y. C. Chen, M. F. Krummel, and S. D. Rosen. 2012. Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells. J. Immunol. 189 : 3914 - 3924.
50. Nakasaki, T., T. Tanaka, S. Okudaira, M. Hirosawa, E. Umemoto, K. Otani, S. Jin, Z. Bai, H. Hayasaka, Y. Fukui, et al. 2008. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am. J. Pathol. 173 : 1566 - 1576.
51. van Meeteren, L. A., and W. H. Moolenaar. 2007. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46 : 145 - 160.
52. Budd, D. C., and Y. Qian. 2013. Development of lysophosphatidic acid pathway modulators as therapies for fi brosis. Future Med. Chem. 5 : 1935 - 1952.
53. Mutoh, T., R. Rivera, and J. Chun. 2012. Insights into the pharmacological relevance of lysophospholipid receptors. Br. J. Pharmacol. 165 : 829 - 844.
54. Ma, L., J. Nagai, J. Chun, and H. Ueda. 2013. An LPA species (18:1 LPA) plays key roles in the self-amplifi cation of spinal LPA production in the peripheral neuropathic pain model. Mol. Pain. 9 : 29.
55. Bourgoin, S. G., and C. Zhao. 2010. Autotaxin and lysophospholipids in rheumatoid arthritis. Curr. Opin. Investig. Drugs. 11 : 515 - 526.
56. Rancoule, C., R. Dusaulcy, K. Treguer, S. Gres, C. Guigne, D. Quilliot, P. Valet, and J. S. Saulnier-Blache. 2012. Depot-specifi c regulation of autotaxin with obesity in human adipose tissue. J. Physiol. Biochem. 68 : 635 - 644.
57. Benesch, M. G., Y. M. Ko, T. P. McMullen, and D. N. Brindley. 2014. Autotaxin in the crosshairs: Taking aim at cancer and other infl ammatory conditions. FEBS Lett. 588 : 2712 - 2727.
58. Tomsig, J. L., A. H. Snyder, E. V. Berdyshev, A. Skobeleva, C. Mataya, V. Natarajan, D. N. Brindley, and K. R. Lynch. 2009. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem. J. 419 : 611 - 618.
59. Long, J. S., K. Yokoyama, G. Tigyi, N. J. Pyne, and S. Pyne. 2006. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid- And platelet-derived-growth-factor-induced cell migration. Biochem. J. 394 : 495 - 500.
60. Pilquil, C., J. Dewald, A. Cherney, I. Gorshkova, G. Tigyi, D. English, V. Natarajan, and D. N. Brindley. 2006. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fi broblast migration by controlling phospholipase D2-dependent phosphatidate generation. J. Biol. Chem. 281 : 38418 - 38429.
61. Benesch, M. G. K., Y. Y. Zhao, J. M. Curtis, T. P. W. McMullen, and D. N. Brindley. 2015. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine-1-phosphate J. Lipid Res. 56 : 1134 - 1144.
62. Jasinska, R., Q. X. Zhang, C. Pilquil, I. Singh, J. Xu, J. Dewald, D. A. Dillon, L. G. Berthiaume, G. M. Carman, D. W. Waggoner, et al. 1999. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters. Biochem. J. 340 : 677 - 686.
63. Salous, A. K., M. Panchatcharam, M. Sunkara, P. Mueller, A. Dong, Y. Wang, G. A. Graf, S. S. Smyth, and A. J. Morris. 2013. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J. Lipid Res. 54 : 2775 - 2784.
64. English, D., Z. Welch, A. T. Kovala, K. Harvey, O. V. Volpert, D. N. Brindley, and J. G. Garcia. 2000. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 14 : 2255 - 2265.
65. Takabe, K., S. W. Paugh, S. Milstien, and S. Spiegel. 2008. "Insideout" signaling of sphingosine-1-phosphate: Therapeutic targets. Pharmacol. Rev. 60 : 181 - 195.
66. Maceyka, M., K. B. Harikumar, S. Milstien, and S. Spiegel. 2012. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22 : 50 - 60.
67. Sato, K., E. Malchinkhuu, Y. Horiuchi, C. Mogi, H. Tomura, M. Tosaka, Y. Yoshimoto, A. Kuwabara, and F. Okajima. 2007. Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J. Neurochem. 103 : 2610 - 2619.
68. Kobayashi, N., T. Nishi, T. Hirata, A. Kihara, T. Sano, Y. Igarashi, and A. Yamaguchi. 2006. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res. 47 : 614 - 621.
69. Ulrych, T., A. Bohm, A. Polzin, G. Daum, R. M. Nusing, G. Geisslinger, T. Hohlfeld, K. Schror, and B. H. Rauch. 2011. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J. Thromb. Haemost. 9 : 790 - 798.
70. Mendoza, A., B. Breart, W. D. Ramos-Perez, L. A. Pitt, M. Gobert, M. Sunkara, J. J. Lafaille, A. J. Morris, and S. R. Schwab. 2012. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Reports. 2 : 1104 - 1110.
71. Peest, U., S. C. Sensken, P. Andreani, P. Hanel, P. P. Van Veldhoven, and M. H. Graler. 2008. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J. Cell. Biochem. 104 : 756 - 772.
72. Zhao, Y., S. K. Kalari, P. V. Usatyuk, I. Gorshkova, D. He, T. Watkins, D. N. Brindley, C. Sun, R. Bittman, J. G. Garcia, et al. 2007. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J. Biol. Chem. 282 : 14165 - 14177.
73. Tang, X., M. G. Benesch, J. Dewald, Y. Y. Zhao, N. Patwardhan, W. L. Santos, J. M. Curtis, T. P. McMullen, and D. N. Brindley. 2014. Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice. J. Lipid Res. 55 : 2389 - 2400.
74. Bréart, B., W. D. Ramos-Perez, A. Mendoza, A. K. Salous, M. Gobert, Y. Huang, R. H. Adams, J. J. Lafaille, D. Escalante-Alcalde, A. J. Morris, et al. 2011. Lipid phosphate phosphatase 3 enables effi cient thymic egress. J. Exp. Med. 208 : 1267 - 1278.
75. López-Juárez, A., S. Morales-Lázaro, R. Sánchez-Sánchez, M. Sunkara, H. Lomelí, I. Velasco, A. J. Morris, and D. Escalante- Alcalde. 2011. Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. Glia. 59 : 577 - 589.
76. Brinkmann, V., A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin. 2010. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9 : 883 - 897.
77. Mechtcheriakova, D., A. Wlachos, J. Sobanov, F. Bornancin, G. Zlabinger, T. Baumruker, and A. Billich. 2007. FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. FEBS Lett. 581 : 3063 - 3068.
78. Yamanaka, M., Y. Anada, Y. Igarashi, and A. Kihara. 2008. A splicing isoform of LPP1, LPP1a, exhibits high phosphatase activity toward FTY720 phosphate. Biochem. Biophys. Res. Commun. 375 : 675 - 679.
79. English, D., Y. Cui, R. Siddiqui, C. Patterson, V. Natarajan, D. N. Brindley, and J. G. Garcia. 1999. Induction of endothelial monolayer permeability by phosphatidate. J. Cell. Biochem. 75 : 105 - 117.
80. Roberts, R. Z., and A. J. Morris. 2000. Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediators. Biochim. Biophys. Acta. 1487 : 33 - 49.
81. Pettus, B. J., K. Kitatani, C. E. Chalfant, T. A. Taha, T. Kawamori, J. Bielawski, L. M. Obeid, and Y. A. Hannun. 2005. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol. 68 : 330 - 335.
82. Humtsoe, J. O., S. Feng, G. D. Thakker, J. Yang, J. Hong, and K. K. Wary. 2003. Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP. EMBO J. 22 : 1539 - 1554.
83. Humtsoe, J. O., R. A. Bowling, Jr., S. Feng, and K. K. Wary. 2005. Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand. Biochem. Biophys. Res. Commun. 335 : 906 - 919.
84. Barilà, D., M. Plateroti, F. Nobili, A. O. Muda, Y. Xie, T. Morimoto, and G. Perozzi. 1996. The Dri 42 gene, whose expression is upregulated during epithelial differentiation, encodes a novel endoplasmic reticulum resident transmembrane protein. J. Biol. Chem. 271 : 29928 - 29936.
85. Pyne, S., K. C. Kong, and P. I. Darroch. 2004. Lysophosphatidic acid and sphingosine 1-phosphate biology: The role of lipid phosphate phosphatases. Semin. Cell Dev. Biol. 15 : 491 - 501.
86. Nishioka, T., M. A. Frohman, M. Matsuda, and E. Kiyokawa. 2010. Heterogeneity of phosphatidic acid levels and distribution at the plasma membrane in living cells as visualized by a Foster resonance energy transfer (FRET) biosensor. J. Biol. Chem. 285 : 35979 - 35987.
87. Rizzo, M. A., K. Shome, C. Vasudevan, D. B. Stolz, T. C. Sung, M. A. Frohman, S. C. Watkins, and G. Romero. 1999. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 274 : 1131 - 1139.
88. Andresen, B. T., M. A. Rizzo, K. Shome, and G. Romero. 2002. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett. 531 : 65 - 68.
89. Alderton, F., S. Rakhit, K. C. Kong, T. Palmer, B. Sambi, S. Pyne, and N. J. Pyne. 2001. Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells. J. Biol. Chem. 276 : 28578 - 28585.
90. Sciorra, V. A., and A. J. Morris. 1999. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol. Biol. Cell. 10 : 3863 - 3876.
91. Gutiérrez-Martínez, E., I. Fernández-Ulibarri, F. Lázaro-Diéguez, L. Johannes, S. Pyne, E. Sarri, and G. Egea. 2013. Lipid phosphate phosphatase 3 participates in transport carrier formation and protein traffi cking in the early secretory pathway. J. Cell Sci. 126 : 2641 - 2655.
92. Long, J., P. Darroch, K. F. Wan, K. C. Kong, N. Ktistakis, N. J. Pyne, and S. Pyne. 2005. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem. J. 391 : 25 - 32.
93. Brindley, D. N., C. Pilquil, M. Sariahmetoglu, and K. Reue. 2009. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim. Biophys. Acta. 1791 : 956 - 961.
94. Hait, N. C., J. Allegood, M. Maceyka, G. M. Strub, K. B. Harikumar, S. K. Singh, C. Luo, R. Marmorstein, T. Kordula, S. Milstien, et al. 2009. Regulation of histone acetylation in the nucleus by sphingosine- 1-phosphate. Science. 325 : 1254 - 1257.
95. Alvarez, S. E., K. B. Harikumar, N. C. Hait, J. Allegood, G. M. Strub, E. Y. Kim, M. Maceyka, H. Jiang, C. Luo, T. Kordula, et al. 2010. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 465 : 1084 - 1088.
96. Maceyka, M., S. G. Payne, S. Milstien, and S. Spiegel. 2002. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta. 1585 : 193 - 201.
97. Zhang, N., J. P. Sundberg, and T. Gridley. 2000. Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile. Genesis. 27 : 137 - 140.
98. Morris, K. E., L. M. Schang, and D. N. Brindley. 2006. Lipid phosphate phosphatase-2 activity regulates S-phase entry of the cell cycle in Rat2 fi broblasts. J. Biol. Chem. 281 : 9297 - 9306.
99. Tanyi, J. L., A. J. Morris, J. K. Wolf, X. Fang, Y. Hasegawa, R. Lapushin, N. Auersperg, Y. J. Sigal, R. A. Newman, E. A. Felix, et al. 2003. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res. 63 : 1073 - 1082.
100. Flanagan, J. M., J. M. Funes, S. Henderson, L. Wild, N. Carey, and C. Boshoff. 2009. Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol. Cancer Ther. 8 : 249 - 260.
101. Escalante-Alcalde, D., L. Hernandez, H. Le Stunff, R. Maeda, H. S. Lee, C. Jr Gang, V. A. Sciorra, I. Daar, S. Spiegel, A. J. Morris, et al. 2003. The lipid phosphatase LPP3 regulates extraembryonic vasculogenesis and axis patterning. Development. 130 : 4623 - 4637.
102. Burnett, C., and K. Howard. 2003. Fly and mammalian lipid phosphate phosphatase isoforms differ in activity both in vitro and in vivo. EMBO Rep. 4 : 793 - 799.
103. Ile, K. E., R. Tripathy, V. Goldfi nger, and A. D. Renault. 2012. Wunen, a Drosophila lipid phosphate phosphatase, is required for septate junction-mediated barrier function. Development. 139 : 2535 - 2546.
104. Renault, A. D., P. S. Kunwar, and R. Lehmann. 2010. Lipid phosphate phosphatase activity regulates dispersal and bilateral sorting of embryonic germ cells in Drosophila. Development. 137 : 1815 - 1823.
105. Pierrugues, O., C. Brutesco, J. Oshiro, M. Gouy, Y. Deveaux, G. M. Carman, P. Thuriaux, and M. Kazmaier. 2001. Lipid phosphate phosphatases in Arabidopsis. Regulation of the AtLPP1 gene in response to stress. J. Biol. Chem. 276 : 20300 - 20308.
106. Escalante-Alcalde, D., S. L. Morales, and C. L. Stewart. 2009. Generation of a reporter-null allele of Ppap2b/Lpp3 and its expression during embryogenesis. Int. J. Dev. Biol. 53 : 139 - 147.
107. Panchatcharam, M., A. K. Salous, J. Brandon, S. Miriyala, J. Wheeler, P. Patil, M. Sunkara, A. J. Morris, D. Escalante-Alcalde, and S. S. Smyth. 2014. Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular infl ammation and permeability. Arterioscler. Thromb. Vasc. Biol. 34 : 837 - 845.
108. Panchatcharam, M., S. Miriyala, A. Salous, J. Wheeler, A. Dong, P. Mueller, M. Sunkara, D. Escalante-Alcalde, A. J. Morris, and S. S. Smyth. 2013. Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 33 : 52 - 59.
109. Senda, K., K. Koizumi, O. Prangsaengtong, T. Minami, S. Suzuki, I. Takasaki, Y. Tabuchi, H. Sakurai, Y. Doki, T. Misaki, et al. 2009. Inducible capillary formation in lymphatic endothelial cells by blocking lipid phosphate phosphatase-3 activity. Lymphat. Res. Biol. 7 : 69 - 74.
110. Schunkert, H., I. R. König, S. Kathiresan, M. P. Reilly, T. L. Assimes, H. Holm, M. Preuss, A. F. Stewart, M. Barbalic, C. Gieger, et al. 2011. Large-scale association analysis identifi es 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43 : 333 - 338.
111. Erbilgin, A., M. Civelek, C. E. Romanoski, C. Pan, R. Hagopian, J. A. Berliner, and A. J. Lusis. 2013. Identifi cation of CAD candidate genes in GWAS loci and their expression in vascular cells. J. Lipid Res. 54 : 1894 - 1905.
112. López-Mejías, R., F. Genre, M. Garcia-Bermúdez, B. Ubilla, S. Castañeda, J. Llorca, C. González-Juanatey, A. Corrales, J. A. Miranda-Filloy, T. Pina, et al. 2014. Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima- media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. Mediators Infl amm. 2014 : 756279.
113. Yukiura, H., K. Hama, K. Nakanaga, M. Tanaka, Y. Asaoka, S. Okudaira, N. Arima, A. Inoue, T. Hashimoto, H. Arai, et al. 2011. Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafi sh. J. Biol. Chem. 286 : 43972 - 43983.
114. Moolenaar, W. H., A. J. Houben, S. J. Lee, and L. A. van Meeteren. 2013. Autotaxin in embryonic development. Biochim. Biophys. Acta. 1831 : 13 - 19.
115. English, D., A. T. Kovala, Z. Welch, K. A. Harvey, R. A. Siddiqui, D. N. Brindley, and J. G. Garcia. 1999. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J. Hematother. Stem Cell Res. 8 : 627 - 634.
116. English, D., D. N. Brindley, S. Spiegel, and J. G. Garcia. 2002. Lipid mediators of angiogenesis and the signalling pathways they initiate. Biochim. Biophys. Acta. 1582 : 228 - 239.
117. Tanimoto, T., Z. G. Jin, and B. C. Berk. 2002. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J. Biol. Chem. 277 : 42997 - 43001.
118. Heo, K., K. A. Park, Y. H. Kim, S. H. Kim, Y. S. Oh, I. H. Kim, S. H. Ryu, and P. G. Suh. 2009. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep. 42 : 685 - 690.
119. Sun, H. Y., S. P. Wei, R. C. Xu, P. X. Xu, and W. C. Zhang. 2010. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. Biochem. Biophys. Res. Commun. 395 : 361 - 366.
120. Balthasar, S., N. Bergelin, C. Lof, M. Vainio, S. Andersson, and K. Tornquist. 2008. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Endocr. Relat. Cancer. 15 : 521 - 534.
121. Boucharaba, A., B. Guillet, F. Menaa, M. Hneino, A. J. van Wijnen, P. Clezardin, and O. Peyruchaud. 2009. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms. Oncol. Res. 18 : 173 - 184. [Erratum. 2009. Oncol. Res. 18: 357.].
122. Kerage, D., D. N. Brindley, and D. G. Hemmings. 2014. Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate. Placenta. 35 ( Suppl ): S86 - S92.
123. Sanchez, T., T. Estrada-Hernandez, J. H. Paik, M. T. Wu, K. Venkataraman, V. Brinkmann, K. Claffey, and T. Hla. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278 : 47281 - 47290.
124. Humtsoe, J. O., M. Liu, A. B. Malik, and K. K. Wary. 2010. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol. Cell. Biol. 30 : 1593 - 1606.
125. Samadi, N., R. Bekele, D. Capatos, G. Venkatraman, M. Sariahmetoglu, and D. N. Brindley. 2011. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie. 93 : 61 - 70.
126. Euer, N., M. Schwirzke, V. Evtimova, H. Burtscher, M. Jarsch, D. Tarin, and U. H. Weidle. 2002. Identifi cation of genes associated with metastasis of mammary carcinoma in metastatic versus nonmetastatic cell lines. Anticancer Res. 22 : 733 - 740.
127. Liu, S., M. Umezu-Goto, M. Murph, Y. Lu, W. Liu, F. Zhang, S. Yu, L. C. Stephens, X. Cui, G. Murrow, et al. 2009. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 15 : 539 - 550.
128. So, J., F. Q. Wang, J. Navari, J. Schreher, and D. A. Fishman. 2005. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2). Gynecol. Oncol. 97 : 870 - 878.
129. Murph, M. M., J. Hurst-Kennedy, V. Newton, D. N. Brindley, and H. Radhakrishna. 2007. Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells. Mol. Cancer Res. 5 : 1201 - 1211.
130. Fang, X., M. Schummer, M. Mao, S. Yu, F. H. Tabassam, R. Swaby, Y. Hasegawa, J. L. Tanyi, R. LaPushin, A. Eder, et al. 2002. Lysophosphatidic acid is a bioactive mediator in ovarian cancer. Biochim. Biophys. Acta. 1582 : 257 - 264.
131. Baker, D. L., P. Morrison, B. Miller, C. A. Riely, B. Tolley, A. M. Westermann, J. M. Bonfrer, E. Bais, W. H. Moolenaar, and G. Tigyi. 2002. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. 287 : 3081 - 3082.
132. Li, H., D. Wang, H. Zhang, K. Kirmani, Z. Zhao, R. Steinmetz, and Y. Xu. 2009. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer Ther. 8 : 1692 - 1701.
133. Sun, B., J. Nishihira, M. Suzuki, N. Fukushima, T. Ishibashi, M. Kondo, Y. Sato, and S. Todo. 2003. Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int. J. Mol. Med. 12 : 633 - 641.
134. Popnikolov, N. K., B. H. Dalwadi, J. D. Thomas, G. J. Johannes, and W. T. Imagawa. 2012. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma. Tumour Biol. 33 : 2237 - 2243.
135. Samadi, N., C. Gaetano, I. S. Goping, and D. N. Brindley. 2009. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene. 28 : 1028 - 1039.
136. Samadi, N., R. T. Bekele, I. S. Goping, L. M. Schang, and D. N. Brindley. 2011. Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from Taxol-induced mitotic arrest. PLoS ONE. 6 : e20608.
137. Zhang, R., J. Wang, S. Ma, Z. Huang, and G. Zhang. 2011. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells. BMC Cell Biol. 12 : 11.
138. Vidot, S., J. Witham, R. Agarwal, S. Greenhough, H. S. Bamrah, G. J. Tigyi, S. B. Kaye, and A. Richardson. 2010. Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. Cell. Signal. 22 : 926 - 935.
139. Bekele, R. T., and D. N. Brindley. 2012. Role of autotaxin and lysophosphatidate in cancer progression and resistance to chemotherapy and radiotherapy. Clin. Lipidol. 7 : 313 - 328.
140. Deng, W., E. Shuyu, R. Tsukahara, W. J. Valentine, G. Durgam, V. Gududuru, L. Balazs, V. Manickam, M. Arsura, L. VanMiddlesworth, et al. 2007. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 132 : 1834 - 1851.
141. Venkatraman, G., M. G. Benesch, X. Tang, J. Dewald, T. P. McMullen, and D. N. Brindley. 2015. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment. FASEB J. 29 : 772 - 785.
142. Fukuhara, S., S. Simmons, S. Kawamura, A. Inoue, Y. Orba, T. Tokudome, Y. Sunden, Y. Arai, K. Moriwaki, J. Ishida, et al. 2012. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte traffi cking in mice. J. Clin. Invest. 122 : 1416 - 1426.
143. Sukocheva, O., L. Wang, E. Verrier, M. A. Vadas, and P. Xia. 2009. Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology. 150 : 4484 - 4492.
144. Brindley, D. N., F. T. Lin, and G. J. Tigyi. 2013. Role of the autotaxinlysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim. Biophys. Acta. 1831 : 74 - 85.
145. Pyne, N. J., and S. Pyne. 2010. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer. 10 : 489 - 503.
146. Benesch, M. G., X. Tang, T. Maeda, A. Ohhata, Y. Y. Zhao, B. P. Kok, J. Dewald, M. Hitt, J. M. Curtis, T. P. McMullen, et al. 2014. Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice. FASEB J. 28 : 2655 - 2666.
147. Kapitonov, D., J. C. Allegood, C. Mitchell, N. C. Hait, J. A. Almenara, J. K. Adams, R. E. Zipkin, P. Dent, T. Kordula, S. Milstien, et al. 2009. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res. 69 : 6915 - 6923.
148. Leong, W. I., and J. D. Saba. 2010. S1P metabolism in cancer and other pathological conditions. Biochimie. 92 : 716 - 723.
149. Curtis, C., S. P. Shah, S. F. Chin, G. Turashvili, O. M. Rueda, M. J. Dunning, D. Speed, A. G. Lynch, S. Samarajiwa, Y. Yuan, et al. 2012. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature. 486 : 346 - 352.
150. Bhattacharjee, A., W. G. Richards, J. Staunton, C. Li, S. Monti, P. Vasa, C. Ladd, J. Beheshti, R. Bueno, M. Gillette, et al. 2001. Classifi cation of human lung carcinomas by mRNA expression profi ling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA. 98 : 13790 - 13795.
151. Yoshihara, K., A. Tajima, D. Komata, T. Yamamoto, S. Kodama, H. Fujiwara, M. Suzuki, Y. Onishi, M. Hatae, K. Sueyoshi, et al. 2009. Gene expression profi ling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci. 100 : 1421 - 1428.
152. Rhodes, D. R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan. 2004. ONCOMINE: A cancer microarray database and integrated datamining platform. Neoplasia. 6 : 1 - 6.
153. Rhodes, D. R., S. Kalyana-Sundaram, V. Mahavisno, R. Varambally, J. Yu, B. B. Briggs, T. R. Barrette, M. J. Anstet, C. Kincead-Beal, P. Kulkarni, et al. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profi les. Neoplasia. 9 : 166 - 180.
154. Tanyi, J. L., Y. Hasegawa, R. Lapushin, A. J. Morris, J. K. Wolf, A. Berchuck, K. Lu, D. I. Smith, K. Kalli, L. C. Hartmann, et al. 2003. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin. Cancer Res. 9 : 3534 - 3545.
155. Imai, A., T. Furui, T. Tamaya, and G. B. Mills. 2000. A gonadotropin- releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. J. Clin. Endocrinol. Metab. 85 : 3370 - 3375.
156. Zhao, Y., P. V. Usatyuk, R. Cummings, B. Saatian, D. He, T. Watkins, A. Morris, E. W. Spannhake, D. N. Brindley, and V. Natarajan. 2005. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem. J. 385 : 493 - 502.
157. Nakayama, J., T. A. Raines, K. R. Lynch, and J. K. Slack-Davis. 2015. Decreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1. PLoS ONE. 10 : e0120071.
158. Lee, S. C., Y. Fujiwara, J. Liu, J. Yue, Y. Shimizu, D. D. Norman, Y. Wang, R. Tsukahara, E. Szabo, R. Patil, et al. 2015. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis. Mol. Cancer Res. 13 : 174 - 185.
159. Kai, M., F. Sakane, Y. J. Jia, S. Imai, S. Yasuda, and H. Kanoh. 2006. Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts. J. Biochem. 140 : 677 - 686.